Question 1

What is the catalog number for 3,4-Dihydroxybenzonitrile 99+% (HPLC)?

Accepted Answer

The catalog number for 3,4-Dihydroxybenzonitrile 99+% (HPLC) is 232247.

Question 2

What sizes are available for 3,4-Dihydroxybenzonitrile 99+% (HPLC)?

Accepted Answer

3,4-Dihydroxybenzonitrile 99+% (HPLC) is available in the following size(s): 1 g, 5 g, 25 g, 100 g, 250 g.

Question 3

How many pack sizes does 3,4-Dihydroxybenzonitrile 99+% (HPLC) come in?

Accepted Answer

3,4-Dihydroxybenzonitrile 99+% (HPLC) is available in 5 different pack sizes.

Question 4

Is 3,4-Dihydroxybenzonitrile 99+% (HPLC) in stock?

Accepted Answer

3,4-Dihydroxybenzonitrile 99+% (HPLC) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 6

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 7

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

3,4-Dihydroxybenzonitrile 99+% (HPLC)

Product Specifications

Available Sizes

Frequently Asked Questions

Explore Other Products

hCG alpha antibody (HRP)

FHR-5 Lentiviral Activation Particles (h2)

ARHGEF1 Rabbit Polyclonal Antibody (Fluoro488)

Recombinant Escherichia coli yqhA Protein (aa 1-164) (strain K12 / DH10B)

Rpl36al 3'UTR Lenti-reporter-Luc Vector

KRIBIOLISA™ Sutimlimab ELISA